Literature DB >> 20971880

Oxidation of Z α1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema.

Sam Alam1, Zhenjun Li, Sabina Janciauskiene, Ravi Mahadeva.   

Abstract

The acceleration of chronic obstructive pulmonary disease (COPD) by cigarette smoke (CS) in individuals with severe genetic deficiency of α(1)-antitrypsin (Z-AT [Glu342Lys]) exemplifies the critical importance of gene-environmental interactions to the development of COPD. We investigated the molecular basis for the interaction between Z-AT and CS. Female mice (8-10 wk old) transgenic for normal (M-AT) or Z-AT on CBA background were exposed to four 1R3F cigarettes daily for 5 days. Age and sex matched littermates not exposed to CS were used as controls. Bronchoalveolar lavage fluid and lung homogenates were assessed for inflammatory cells, neutrophil elastase, and AT conformers. Z-AT was purified from plasma, exposed to CS extract, and assessed for the development and temporal relationship between AT conformers. Mice transgenic for Z-AT developed a significant increase in pulmonary polymers after acute CS exposure (P = 0.001). There were also increased neutrophils in CS-Z lungs versus controls (P < 0.001), which were tightly correlated with polymer concentrations (r(2) = 0.93). Oxidation of human plasma Z-AT by CS or N-chlorosuccinimide greatly accelerated polymerization (P = 0.004), which could be abrogated by antioxidants (P = 0.359 versus Z control). Our data show that CS accelerates polymerization of Z-AT by oxidative modification, which, in so doing, further reduces pulmonary defense and increases neutrophil influx into the lungs. These novel findings provide a molecular explanation for the striking observation of premature emphysema in ZZ homozygotes who smoke. Further work is required to assess whether antioxidant therapy may be beneficial in Z-AT-related COPD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971880     DOI: 10.1165/rcmb.2010-0328OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  38 in total

1.  Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases.

Authors:  Angelia D Lockett; Mary Van Demark; Yuan Gu; Kelly S Schweitzer; Ninotchka Sigua; Krzysztof Kamocki; Iwona Fijalkowska; Jana Garrison; Amanda J Fisher; Karina Serban; Robert A Wise; Terence R Flotte; Christian Mueller; Robert G Presson; Horia I Petrache; Rubin M Tuder; Irina Petrache
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 2.  Antioxidant pharmacological therapies for COPD.

Authors:  Irfan Rahman; William MacNee
Journal:  Curr Opin Pharmacol       Date:  2012-02-18       Impact factor: 5.547

3.  Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells.

Authors:  Ying-Hua Chang; Shu-Hui Lee; I-Chuang Liao; Shin-Huei Huang; Hung-Chi Cheng; Pao-Chi Liao
Journal:  Mol Cell Proteomics       Date:  2012-08-15       Impact factor: 5.911

4.  Impact of HIV infection on α1-antitrypsin in the lung.

Authors:  Sarah E Stephenson; Carole L Wilson; Kristina Crothers; Engi F Attia; Cherry Wongtrakool; Irina Petrache; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

Review 5.  Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Authors:  Esther Barreiro; Víctor Bustamante; Víctor Curull; Joaquim Gea; José Luis López-Campos; Xavier Muñoz
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 6.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

7.  Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Authors:  Kevin Molloy; Craig P Hersh; Valerie B Morris; Tomás P Carroll; Catherine A O'Connor; Jessica A Lasky-Su; Catherine M Greene; Shane J O'Neill; Edwin K Silverman; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

8.  Redox Imbalance in Lung Cancer of Patients with Underlying Chronic Respiratory Conditions.

Authors:  Mercè Mateu-Jiménez; Albert Sánchez-Font; Alberto Rodríguez-Fuster; Rafael Aguilό; Lara Pijuan; Clara Fermoselle; Joaquim Gea; Victor Curull; Esther Barreiro
Journal:  Mol Med       Date:  2016-01-07       Impact factor: 6.354

Review 9.  Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental Factors.

Authors:  Madhu Rangaraju; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

10.  Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease.

Authors:  Samuel Alam; Zhenjun Li; Carl Atkinson; Danny Jonigk; Sabina Janciauskiene; Ravi Mahadeva
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.